BACKGROUND AND OBJECTIVE: Acute and early human immunodeficiency virus infection (AEH) is accompanied by neuroinflammatory processes as well as impairment in neurocognitive and everyday functions, but little is known about the frequency and clinical correlates of the neurobehavioral disturbances during this period. We compared pre-seroconversion with current levels of apathy, disinhibition, and executive dysfunction; we also examined everyday function and HIV disease correlates of neuropsychiatric impairment in individuals with AEH. METHODS: In this study, 34 individuals with AEH and 39 HIV-seronegative participants completed neuromedical and neuropsychological assessments, a structured psychiatric interview, and the apathy, disinhibition, and executive dysfunction subscales of the Frontal Systems Behavioral Scale. RESULTS: Independent of any substance use and mood disorders, the AEH group had significantly higher levels of current apathy and executive dysfunction than the controls, but not greater disinhibition. Retrospective ratings of pre-seroconversion levels of apathy, disinhibition, and executive dysfunction were all higher in the AEH group than the controls. After seroconversion, the AEH cohort had increases in current apathy and executive dysfunction, but not disinhibition. In the AEH cohort, higher current global neurobehavioral dysfunction was significantly associated with lower nadir CD4 counts, slowed information processing speed, and more everyday function problems. CONCLUSIONS: These data suggest that individuals who have recently acquired HIV experienced higher-than-normal premorbid levels of neurobehavioral disturbance. Apathy and executive dysfunction are exacerbated during AEH, particularly in association with lower CD4 counts.
BACKGROUND AND OBJECTIVE: Acute and early humanimmunodeficiency virus infection (AEH) is accompanied by neuroinflammatory processes as well as impairment in neurocognitive and everyday functions, but little is known about the frequency and clinical correlates of the neurobehavioral disturbances during this period. We compared pre-seroconversion with current levels of apathy, disinhibition, and executive dysfunction; we also examined everyday function and HIV disease correlates of neuropsychiatric impairment in individuals with AEH. METHODS: In this study, 34 individuals with AEH and 39 HIV-seronegative participants completed neuromedical and neuropsychological assessments, a structured psychiatric interview, and the apathy, disinhibition, and executive dysfunction subscales of the Frontal Systems Behavioral Scale. RESULTS: Independent of any substance use and mood disorders, the AEH group had significantly higher levels of current apathy and executive dysfunction than the controls, but not greater disinhibition. Retrospective ratings of pre-seroconversion levels of apathy, disinhibition, and executive dysfunction were all higher in the AEH group than the controls. After seroconversion, the AEH cohort had increases in current apathy and executive dysfunction, but not disinhibition. In the AEH cohort, higher current global neurobehavioral dysfunction was significantly associated with lower nadirCD4 counts, slowed information processing speed, and more everyday function problems. CONCLUSIONS: These data suggest that individuals who have recently acquired HIV experienced higher-than-normal premorbid levels of neurobehavioral disturbance. Apathy and executive dysfunction are exacerbated during AEH, particularly in association with lower CD4 counts.
Authors: Terry R Barclay; Charles H Hinkin; Steven A Castellon; Karen I Mason; Matthew J Reinhard; Sarah D Marion; Andrew J Levine; Ramani S Durvasula Journal: Health Psychol Date: 2007-01 Impact factor: 4.267
Authors: Michael W Plankey; David G Ostrow; Ron Stall; Christopher Cox; Xiuhong Li; James A Peck; Lisa P Jacobson Journal: J Acquir Immune Defic Syndr Date: 2007-05-01 Impact factor: 3.731
Authors: A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna Journal: Neurology Date: 2007-10-03 Impact factor: 9.910
Authors: M R Lentz; W K Kim; V Lee; S Bazner; E F Halpern; N Venna; K Williams; E S Rosenberg; R G González Journal: Neurology Date: 2009-04-28 Impact factor: 9.910
Authors: Jose A Muñoz-Moreno; Carmina R Fumaz; Maria J Ferrer; Anna Prats; Eugènia Negredo; Maite Garolera; Núria Pérez-Alvarez; José Moltó; Guadalupe Gómez; Bonaventura Clotet Journal: AIDS Res Hum Retroviruses Date: 2008-10 Impact factor: 2.205
Authors: B M Ances; D Sisti; F Vaida; C L Liang; O Leontiev; J E Perthen; R B Buxton; D Benson; D M Smith; S J Little; D D Richman; D J Moore; R J Ellis Journal: Neurology Date: 2009-09-01 Impact factor: 9.910
Authors: J Hampton Atkinson; Jenny A Higgins; Ofilio Vigil; Robert Dubrow; Robert H Remien; Wayne T Steward; Corinna Young Casey; Kathleen J Sikkema; Jackie Correale; Chris Ake; J Allen McCutchan; Peter R Kerndt; Stephen F Morin; Igor Grant Journal: AIDS Behav Date: 2009-06-11
Authors: Peter R Kerndt; Robert Dubrow; Getahun Aynalem; Kenneth H Mayer; Curt Beckwith; Robert H Remien; Hong-Ha M Truong; Apurva Uniyal; Michael Chien; Ronald A Brooks; Ofilio R Vigil; Wayne T Steward; Michael Merson; Mary Jane Rotheram-Borus; Stephen F Morin Journal: AIDS Behav Date: 2009-06-03
Authors: Sarah Tymchuk; Daniela Gomez; Noshin Koenig; M John Gill; Esther Fujiwara; Christopher Power Journal: Can J Psychiatry Date: 2017-12-11 Impact factor: 4.356
Authors: Martin Hoenigl; Erin Morgan; Donald Franklin; Peter L Anderson; Elizabeth Pasipanodya; Matthew Dawson; Marvin Hanashiro; Eric E Ellorin; Jill Blumenthal; Robert Heaton; David J Moore; Sheldon R Morris Journal: J Neurovirol Date: 2019-01-07 Impact factor: 2.643
Authors: Steven Paul Woods; Jennifer L Thompson; Michelle A Babicz; Lokesh Shahani; Gabriela Delevati Colpo; Natalia P Rocha; Erin E Morgan; Antonio L Teixeira Journal: J Psychosom Res Date: 2021-11-08 Impact factor: 4.620
Authors: Caitlin N Pope; Jessica L Montoya; Elizabeth Vasquez; Josué Pérez-Santiago; Ronald Ellis; J Allen McCutchan; Dilip V Jeste; David J Moore; María J Marquine Journal: J Neurovirol Date: 2020-07-30 Impact factor: 2.643
Authors: Raha M Dastgheyb; Ned Sacktor; Donald Franklin; Scott Letendre; Thomas Marcotte; Robert Heaton; Igor Grant; Justin C McArthur; Leah H Rubin; Norman J Haughey Journal: J Acquir Immune Defic Syndr Date: 2019-09-01 Impact factor: 3.771